Open access · OA
via OpenAlex
Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis
Kirsteen H. Maclean, Frank Charles Dorsey, John L. Cleveland, Michael B. Kastan
Journal of Clinical Investigation · 2007 · ▲ 274 citations
Abstract
Despite great interest in cancer chemoprevention, effective agents are few. Here we show that chloroquine, a drug that activates the stress-responsive Atm-p53 tumor-suppressor pathway, preferentially enhances the death of Myc oncogene-overexpressing primary mouse B cells and mouse embryonic fibroblasts (MEFs) and impairs Myc-induced lymphomagenesis in a transgenic mouse model of human Burkitt lymphoma. Chloroquine-induced cell death in primary MEFs and human colorectal cancer cells was dependent upon p53, but not upon the p53 modulators Atm or Arf. Accordingly, chloroquine impaired spontaneous lymphoma development in Atm-deficient mice, a mouse model of ataxia telangiectasia, but not in p53-deficient mice. Chloroquine treatment enhanced markers of both macroautophagy and apoptosis in MEFs but ultimately impaired lysosomal protein degradation. Interestingly, chloroquine-induced cell death was not dependent on caspase-mediated apoptosis, as neither overexpression of the antiapoptotic protein Bcl-2 nor deletion of the proapoptotic Bax and Bak affected chloroquine-induced MEF death. However, when both apoptotic and autophagic pathways were blocked simultaneously, chloroquine-induced killing of Myc-overexpressing cells was blunted. Thus chloroquine induces lysosomal stress and provokes a p53-dependent cell death that does not require caspase-mediated apoptosis. These findings specifically demonstrate that intermittent chloroquine use effectively prevents cancer in mouse models of 2 genetically distinct human cancer syndromes, Burkitt lymphoma and ataxia telangiectasia, suggesting that agents targeting lysosome-mediated degradation may be effective in cancer prevention.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1172/jci33700
- Canonical
- link ↗
- Fetched
- 2026-09-27 MST
Cite this
APA
Maclean, K.H., Dorsey, F.C., Cleveland, J.L., & Kastan, M.B. (2007). Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. <em>Journal of Clinical Investigation</em>. https://doi.org/10.1172/jci33700
Vancouver
Maclean KH, Dorsey FC, Cleveland JL, Kastan MB. Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. Journal of Clinical Investigation. 2007. doi:10.1172/jci33700.
BibTeX
@article{kirsteen2007Target,
title = {Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis},
author = {Kirsteen H. Maclean and Frank Charles Dorsey and John L. Cleveland and Michael B. Kastan},
journal = {Journal of Clinical Investigation},
year = {2007},
doi = {10.1172/jci33700},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Autophagy 2022
Open access · CC-BY
Treatments targeting autophagy ameliorate the age-related macular degeneration phenotype in mice lacking APOE (apolipoprotein E)
Cell Metabolism 2020
Open access · OA
Defined p16High Senescent Cell Types Are Indispensable for Mouse Healthspan
British Journal of Pharmacology 2007
Open access · OA
Telomerase and its potential for therapeutic intervention
Proceedings of the National Academy of Sciences 2019
Open access · CC-BY
Proteostasis collapse is a driver of cell aging and death
Jurnal Kedokteran dan Kesehatan Publikasi Ilmiah Fakultas Kedokteran Universitas Sriwijaya 2025
Open access · CC-BY
ADVANTAGES AND DISADVANTAGES OF USING METFORMIN IN AGING RELATED DISEASES
Cell Research 2019
Open access · OA